Key facts
- It has raised $230K; the latest was Early Stage VC in Oct 2025.
- Notable investors include Assetup, Climate Finance Accelerator, Council for Scientific and Industrial Research, Magnitt Ventures, Ninety One — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for MycoSure
- ·The full record, as it builds
Funding rounds
No funding rounds for MycoSure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MycoSure
Developer of a mycelium-based fermentation technology designed to create natural, bio-based products. The company's technology helps in the transition from extractive and environmentally damaging production methodologies and waste streams to nature-inspired, green chemistry and responsible products that directly address social and environmental challenges, enabling the food and beverage sector to get the supply of branded ingredients and create a healthy and sustainable future based on circular and regenerative alternatives.
- Sector
- Business Products and Services (B2B)
- HQ
- Johannesburg, South Africa
- Founded
- 2021
- Employees
- 3
- Website
- mycosure.co.za/
- Ownership
- Privately Held (backing)
MycoSure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MycoSure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MycoSure in its N-PORT filings yet. We sweep new filings monthly.